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ABSTRACT
Objective: Thickness of the diaphragm was evaluated by B-mode 
ultrasonography (US) in chronic obstructive pulmonary disease 
(COPD) to determine the relationship between diaphragm thickness 
measurement, pulmonary function tests, and symptom scores. 
Patients and Methods: Fifty-three clinically stable patients 
with COPD were enrolled in this study for diaphragmatic thickness 
evaluation with B- mode US. The severity of COPD was determined 
by spirometric measurements in terms of %FEV1. Patients were 
also analyzed according to GOLD criteria. Correlation between 
diaphragm thickness and symptom scores like Medical Research 
Council (mMRC), COPD Assessment Test (CAT), composite 
scores and body mass index (BMI) were sought. 
Results: There was a moderate correlation between 
diaphragmatic muscle thickness and %FEV1 in mild COPD 
patients (r=0.62, p=0.017<0.05).  No significant difference in 
diaphragmatic thicknesses of GOLD subgroups was found. There 
were no correlations between diaphragmatic muscle thickness, 
symptom scores, BMI, age, and gender.
Conclusion: No correlation was found between diaphragmatic 
thickness in COPD patients and pulmonary function tests except 
for %FEV1 in mild COPD patients. There were no correlations 
between diaphragmatic muscle thickness and  symptom scores. 
Further US studies should take place for functional evaluation of 
the diaphragm in COPD subgroups.
Keywords: Diaphragm, Ultrasonography, Chronic obstructive 
pulmonary disease, Thickness.
ÖZ
Amaç: Kronik obstruktive akciğer hastalığı (KOAH) olan 
hastaların,  diyafram kalınlıklarını ultrasonografi ile ölçerek 
solunum fonksiyon testleri ve semptom skorları ile ilişkisinin 
araştırılmasıdır. 
Gereç ve Yöntem: KOAH nedeniyle takip edilmekte olan, 
son iki aydır klinik olarak stabil seyirli 53 hasta çalışmamıza 
dahil edildi. Bronkodilatör sonrası FEV1 değerlerinde %12 artış, 
çalışmada uygulanan testlerden herhangi birine uyumsuzluk, 
oksijen bağımlılığı,  abdominal ya da torasik cerrahi geçirme 
hikayeleri çalışmadan dışlanma kriterleri olarak belirlendi. 
KOAH düzeyi spirometri ölçümlerine ve GOLD kriterlerine göre 
sınıflandırıldı.
Hayat kalitesi değerlendirmesi için mMRC ve CAT semptom 
skorları testleri ile kompozit KOAH skor ölçümü hesaplanması 
için alevlenme sayıları sorularak kaydedildi.
Bulgular: KOAH düzeyi hafif olan hastalarda FEV1 % 
ile diyafram kalınlığı arasında anlamlı ilişki bulundu (r=0.62, 
p=0,017<0,05). Diyafram kalınlığı ile GOLD alt grupları, semptom 
skorları, BMI , yaş ve cinsiyet gibi parametreler arasında anlamlı 
ilişki bulunamadı. 
Sonuç: KOAH hastalarında ultrasonografi ile ölçülen diyafram 
kalınlığı ile solunum fonksiyon testleri arasında hafif KOAH’lı 
hasta grubu haricinde anlamlı ilişki gösterilememiştir. Diyafram 
kalınlığı ile semptom skorları arasında anlamlı ilişki bulunamadı. 
Ultrasonografi ile planlanacak yeni çalışmalarda,  KOAH alt 
gruplarında diyafram fonksiyonunu yansıtacak diyafram kalınlık 
oranları irdelenmelidir.
Anahtar kelimeler: Diyafram, Ultrasonografi, Kronik obstrüktif 
akciğer hastalığı, Kalınlık.
Introduction
Sonographic evaluation of diaphragm has gained wide 
acceptance to assess the presence of postoperative 
diaphragm dysfunction, identify ventilator induced injuries, 
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and evaluate diaphragmatic motion in intensive care units. 
There are ongoing studies about diaphragmatic thickness 
evaluation in search for the correct timing for discontinuation 
of mechanical ventilation and adjustment of ventilator 
settings [1, 2]. 
COPD is mainly defined as a disease characterized 
by airway obstruction and air trapping that is not fully 
reversible. Studies dealing with inspiratory muscle weakness 
in COPD patients focus mostly on diaphragm since it is 
the principal generator of tidal volume [3]. US findings of 
diaphragm muscle in COPD patients is not concluded yet 
because of the varying results [3-7].These studies address 
the structure and the motion of the diaphragm [4]. The 
impairment of diaphragm is suggested to be an important 
factor which is associated with alterations in the principal 
pulmonary function parameters such as FEV1 [8]. In 
our study, diaphragmatic muscle thickness is measured 
in COPD patients with B-Mode US to determine the 
relationship between thickness and clinical and functional 
parameters. Our aim is to determine if US assessment of 
the diaphragm muscle thickness could be a useful tool for 
evaluating diaphragmatic function and disease progression 
in COPD subgroups. 
Patients and Methods
Patients
This prospective study was approved by the Ethics 
Committee of our institution. Informed written consent was 
obtained from all individual participants included in the 
study. Patients were referred from the Pulmonary Diseases 
and Critical Care Department between February 2013 and 
February 2014. Fifty-three patients with COPD (47 male 
and 6 females with a mean age 62.57 ± 10. 1) were enrolled 
in this study for diaphragmatic thickness evaluation with 
US. Clinical history, physical examination, and pulmonary 
function tests (post bronchodilator FEV1/FVC < 0.7) were 
used for COPD diagnosis. Patients under medical treatment 
for COPD and who are clinically stable for at least two 
months period were included in the study. None of the 
subjects were hospitalized because of exacerbations nor did 
they have history of steroid or theophylline treatment. A 
positive response to bronchodilators (an increase in FEV1 
from baseline that is more than 200ml and more than 15 per 
cent of the prebronchodilator value), oxygen dependency, 
discordance between test results,  history of major thoracic or 
abdominal surgery were the exclusion criteria. The severity 
of COPD was determined by spirometric measurements 
as mild (FEV1 >%80), moderate (%80<FEV1 >%50) or 
severe (%50<FEV1 >%30). Patients were also analyzed 
according to GOLD criteria (A, B, C, and D). All patients 
completed questionnaire assessing globally the impact of 
COPD on health status and symptom levels were assessed 
by using the modified Medical Research Council (mMRC) 
dyspnea scale and the COPD Assessment Test (CAT). The 
number of exacerbations was questioned for evaluation of 
composite scores. Body mass index (BMI) and smoking 
status were also recorded. The patient characteristics of the 
study population are shown in Table I.
Table I. Descriptive Statistics
 Minimum Maximum Mean
Std.
Deviation
Diaphragm 
thickness 
(mm.) 0.6 2.8   2.05   0.45
Age 41 78 62.57 9.8
BMI (kg/m2) 18 45 27.70        52.9
Smoking 
(pack/year) 10       120 47.05 25.41
CAT    0 29 12.09   8.58
mMRC    0   4      2   1.12
FEV1 (litre) 0.6 2.8 1.81   0.45
BMI: Body mass index; CAT: COPD Assessment Test;  
mMRC: modified Medical Research Council dyspnea scale
Pulmonary function test
The pulmonary function tests were performed in the 
pulmonary function laboratory of our institution with 
a whole-body plethysmograph (Collins GS II, Collins, 
Braintree, MA, USA). Spirometric parameters, static lung 
volumes, airway resistance and COPD were quantified 
in accordance with the technique recommended by the 
American Thoracic Society and the European Respiratory 
Society, based on criteria of reproducibility and acceptability 
(variation of < 5%) [9]. 
US Technique 
Thickness of the diaphragm muscle at end-expiration 
was measured using B-Mode US. All subjects underwent 
B-mode US examinations in supine position. US was 
performed using a Logiq E9 (GE Healthcare, Milwaukee, 
USA) ultrasound system equipped with a 9-15 MHz linear 
transducer.
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The diaphragm was visualized by placing the transducer 
in the ninth intercostal space perpendicular to two ribs (9th-
10th), between the anterior and the midaxillary lines where 
the zone of apposition can be observed optimally 0.5 to 2 cm 
below the costophrenic sinus (Figure 1). The hypoechoic 
diaphragm muscle lays between two parallel echoic 
lines namely the diaphragmatic pleura and the peritoneal 
membrane. Thickness was measured by placing the 
calipers inside the hyperechoic lines (Figure 2). The patient 
was instructed to perform spontaneous breathing. Three 
diaphragm thickness measurement of the right diaphragm 
were recorded at end-expiration and averaged. Radiologists 
performing B-Mode US was blind to the patient groups.
Figure 1. Transducer placement for intercostal view.
Figure 2. Ultrasound image of diaphragm thickness at end-
expiration (2.4mm). The hypoechoic diaphragm muscle lies 
between two hyperechoic lines namely the diaphragmatic pleura 
and the peritoneal membrane.
Statistical analysis
Statistical analysis was performed with SPSS software 
version 21.0 (SPSS Inc., Chicago, IL). Kolmogorov - 
Smirnov test was used to examine the normal distribution of 
descriptive statistics (frequency, percentile, mean, standard 
deviation). Mann Whitney U test was used to compare the 
quantitative data parameters between groups. Pearson chi-
square test and Fisher’s exact test were used to compare the 
qualitative data parameters. The Spearman coefficient was 
used to evaluate correlations. 
Results
Fifty-three COPD patients (47 male and 6females) with a 
mean age 62.57 ± 10.1 were enrolled in this study.  Average 
BMI was 27.7 ± 5.1 with a minimum value of 18 and 
maximum value of 45. The distribution of COPD patients 
determined by spirometric measurements is as follows: 
mild (n=14), moderate (n=28), severe (n=11). Descriptive 
characteristics are summarized in Table I. 
The diaphragmatic thickness was 2, 03± 0.39mm 
in females and 2, 06±0,55mm in males. There was no 
significant correlation between diaphragmatic muscle 
thickness regarding gender, age, and BMI (p>0.05). There 
was a moderate correlation between diaphragmatic muscle 
thickness and patients with mild COPD (r=0.62, p=0,017<0, 
05). As %FEV1 decreased, the thickness decreased. There 
was no significant correlation between thickness and 
moderate and severe COPD (Tables II, III). 
Table II. Severity of COPD and diaphragm thickness
Mild (n=14)
Moderate 
(n=28)
Severe 
(n=11)
KW p
Mean Std Mean Std Mean Std
Thickness 2.207 0.369 1.975 0.624 2.073 0.476 4.658 0.097
Diaphragm thickness was 2,367mm in GOLD A; 1,8mm 
in GOLD B; 2,014mm in GOLD C; and 2,065mm in GOLD 
D. There was no significant difference in diaphragmatic 
thickness of GOLD A, B, C; D groups (Table IV).
Average mMRC score was 2±1; CAT grade was 12±8. 
There were no correlations between diaphragmatic muscle 
thickness and symptom scores (mMRC, and CAT). 
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Discussion
Despite widespread use of ultrasound for diaphragm 
assessment, there is a lack of reference value for diaphragm 
parameters in patients with COPD. B-mode US can be used 
to assess the thickness of the diaphragm over a wide range of 
lung volumes from residual volume to total lung capacity in 
the zone of apposition (ZOA), with high reproducibility [1, 
7, 10]. Data from a necropsy study indicate that measurement 
of diaphragm thickness with ultrasonography at the ZOA is 
as accurate as measurements performed in vitro with a ruler 
[11]. In our study, diaphragm thickness was measured at 
the ZOA. Measuring diaphragm thickness at end-expiration 
was easy for participants to perform, which is important 
when considering clinical applications in patients with 
limited alertness and cooperation. Diaphragm thickness 
measurements in COPD patients varied in different studies. 
Boon et al. measured diaphragmatic thickness in normal 
subjects in the ZOA and reported the mean value as 3.3mm. 
Diaphragm pathology was suggested for sonographically 
measured thickness less than 1.5mm [12]. McCool et al. 
proposed cutoff value to define diaphragm atrophy to be 
less than 2mm at end-expiration [13]. In our study, the 
mean thickness value was 2.3 mm in females and 2.06 mm 
in males indicating that diaphragm thickness of the patients 
enrolled were influenced by COPD.
There are only a few studies in literature about 
sonographic diaphragm evaluation involving COPD 
patients [3, 4, 7]. Some studies defined the relationship 
between diaphragm mobility in COPD patients where the 
craniocaudal displacement of the portal vein was calculated 
as an indirect measurement of the diaphragm mobility in 
B-mode and M- mode US [3, 5, 6]. Baria et al. had a similar 
study to ours with B-mode US where diaphragmatic thickness 
and thickening ratio were measured in COPD patients 
with coexisting neuromuscular respiratory weakness. No 
significant difference was found between COPD patients 
and healthy groups in terms of diaphragm thickness with the 
exception of a subgroup with severe air trapping so Baria et 
al. concluded that normal values could be applied to COPD 
patients as reference values [4]. 
Sonographic assessment of the diaphragm thickness was 
recently evaluated for disease progression in COPD patients 
in terms of lung volumes. Smargiassi et al. demonstrated that 
the alterations in thickness were related to the volumetric 
changes [7]. They showed that indices of lung hyperinflation 
like VC, FVC, FEV1 were related to the diaphragmatic 
thickening by taking measurements at various lung volumes. 
In our study, we found correlation between diaphragmatic 
muscle thickness and %FEV1 values in mild COPD 
patients. The diaphragm thickness decreased as the lung 
volume decreased. However we could not get significant 
results in moderate and severe COPD patients. Since the 
measurements were made only at the end-expiratory phase, 
we could suggest that the results reflect the structural status 
Table III. Functional and anthopometric characteristics of classification of COPD according to the severity of obstruction
 
n
Mild (n=14) Moderate (n=28) Severe (n=11)
r p n r p n r p
Thickness 
(mm)
smoking 11 -0.533 0.091 24 0.066 0.760 11 -0.012 0.973
BMI 14 0.151 0.606 28 0.083 0.681 11 0.220 0.515
Attack (n) 9 -0.094 0.810 20 0.165 0.486 9 -0.026 0.948
FEV/FVC 14 -0.256 0.378 28 0.035 0.858 11 0.067 0.846
FEV1 % 14 -0.623 0.017 28 -0.209 0.285 11 -0.108 0.752
mMRC 14 -0.431 0.124 28 0.256 0.189 11 0.036 0.917
CAT 14 -0.162 0.580 28 0.006 0.974 11 0.009 0.978
BMI: Body mass index; CAT: COPD Assessment Test; mMRC: modified Medical Research Council dyspnea scale
Table IV.  Diaphragm thickness according to GOLD subgroups
A (n=19) B (n=19) C (n=8) D (n=7)
KW p
Mean Std Mean Std Mean Std Mean Std
Thickness 2.367 0.803 1.800 0.372 2.014 0.308 2.065 0.430 6.492 0.090
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rather than functional features of the diaphragm. The low 
number of patients enrolled in the study might be another 
factor affecting the relationship between COPD severity and 
US measurements.   
Diaphragm thickening fraction (TF) has been newly 
proposed to be more sensitive than measurement of 
thickness since the increase in diaphragmatic thickness 
during inspiration is used as an indirect measurement of 
muscle fiber contraction which is analogous to ejection 
fraction of the heart [14]. TF was calculated as (thickness 
at end inspiration-thickness at end expiration)/ (thickness at 
end expiration) [15]. The assessment of TF by US performed 
as effective as the other weaning indexes in intensive care 
units [1, 2, 15].
COPD affects the lungs, but it also produces significant 
systemic consequences like nutritional abnormality, and 
weight loss [16]. In our study BMI decreased with advancing 
disease stage as expected. However no correlation was found 
between BMI and diaphragm thickness. Muscle wasting is 
called a significant determinant of mortality in severe COPD 
patients. Recent studies suggest that loss of fat free mass 
(FFM) is more accurate than BMI for predicting severity of 
the disease [7].   
The small number of patients enrolled is one of the 
limitations of the study. Having no comparison with any 
other methods that might be considered to be a gold standard 
for assessing diaphragm function is another limitation of our 
study.  Trans-diaphragmatic pressure measurement using 
esophageal or gastric transducers is considered to be the 
gold standard for evaluation of diaphragmatic function [15]. 
Electromyography is also an invasive and uncomfortable 
method and fluoroscopy expose the patients to radiation. 
Ultrasound has been shown to be similar in accuracy to 
most other imaging modalities for diaphragm assessment 
and measurements correlated well with lung volumes and 
inspiratory pressure values [17, 18].
Conclusions
No correlation was found between diaphragmatic thickness 
in COPD patients and pulmonary function tests except for 
%FEV1 in mild COPD patients. There were no correlations 
between diaphragmatic muscle thickness and symptom 
scores. Further US studies assessing thickness fraction 
should take place for functional evaluation of the diaphragm 
in COPD subgroups to determine  disease progression. 
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